The partnership leverages PPD’s pediatric clinical trial experience, regulatory knowledge, and site and pediatric patient networks, and Quotient’s expertise in pediatric formulation development, drug ...
North Carolina-based PPD has established a joint venture with Taijitu Biologics to develop and commercialize a technology platform for the discovery of first- and best-in-class monoclonal antibody ...
A highly sensitive molecular test for tuberculosis (TB) detected Mycobacterium tuberculosis DNA in a surprising proportion of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results